2698 related articles for article (PubMed ID: 7512644)
1. Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice.
Buttery LD; Springall DR; Andrade SP; Riveros-Moreno V; Hart I; Piper PJ; Polak JM
J Pathol; 1993 Dec; 171(4):311-9. PubMed ID: 7512644
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature.
Andrade SP; Hart IR; Piper PJ
Br J Pharmacol; 1992 Dec; 107(4):1092-5. PubMed ID: 1281718
[TBL] [Abstract][Full Text] [Related]
3. Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice.
Thompson WD
J Pathol; 1994 Jul; 173(3):293-4. PubMed ID: 7523646
[No Abstract] [Full Text] [Related]
4. Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats.
Buttery LD; Evans TJ; Springall DR; Carpenter A; Cohen J; Polak JM
Lab Invest; 1994 Nov; 71(5):755-64. PubMed ID: 7526041
[TBL] [Abstract][Full Text] [Related]
5. Functional expression of three isoforms of human nitric oxide synthase in baculovirus-infected insect cells.
Nakane M; Pollock JS; Klinghofer V; Basha F; Marsden PA; Hokari A; Ogura T; Esumi H; Carter GW
Biochem Biophys Res Commun; 1995 Jan; 206(2):511-7. PubMed ID: 7530001
[TBL] [Abstract][Full Text] [Related]
6. Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126.
Cullis ER; Kalber TL; Ashton SE; Cartwright JE; Griffiths JR; Ryan AJ; Robinson SP
Microvasc Res; 2006 Mar; 71(2):76-84. PubMed ID: 16530791
[TBL] [Abstract][Full Text] [Related]
7. Cytokine regulation of nitric oxide synthase in mouse retinal pigment epithelial cells in culture.
Sparrow JR; Nathan C; Vodovotz Y
Exp Eye Res; 1994 Aug; 59(2):129-39. PubMed ID: 7530664
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy.
Korbelik M; Parkins CS; Shibuya H; Cecic I; Stratford MR; Chaplin DJ
Br J Cancer; 2000 Jun; 82(11):1835-43. PubMed ID: 10839299
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions.
de Wilt JH; Manusama ER; van Etten B; van Tiel ST; Jorna AS; Seynhaeve AL; ten Hagen TL; Eggermont AM
Br J Cancer; 2000 Nov; 83(9):1176-82. PubMed ID: 11027431
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids.
Cahlin C; Gelin J; Delbro D; Lönnroth C; Doi C; Lundholm K
Cancer Res; 2000 Mar; 60(6):1742-9. PubMed ID: 10749148
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of tumor-draining lymph nodes and the nitric oxide pathway.
Davel L; Eijan AM; Sales ME; Español A; D'Agostino A; Piccardo I; Lauría L; De Lustig ES; Jasnis MA
Int J Oncol; 2002 Jan; 20(1):59-67. PubMed ID: 11743643
[TBL] [Abstract][Full Text] [Related]
12. Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression.
Laskin DL; Rodriguez del Valle M; Heck DE; Hwang SM; Ohnishi ST; Durham SK; Goller NL; Laskin JD
Hepatology; 1995 Jul; 22(1):223-34. PubMed ID: 7541386
[TBL] [Abstract][Full Text] [Related]
13. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362.
Xie K; Huang S; Dong Z; Gutman M; Fidler IJ
Cancer Res; 1995 Jul; 55(14):3123-31. PubMed ID: 7541713
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma-inducible murine macrophage nitric oxide synthase: studies on the mechanism of inhibition by imidazole agents.
Wolff DJ; Gribin BJ
Arch Biochem Biophys; 1994 Jun; 311(2):293-9. PubMed ID: 7515612
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide as a mediator of bisacodyl and phenolphthalein laxative action: induction of nitric oxide synthase.
Gaginella TS; Mascolo N; Izzo AA; Autore G; Capasso F
J Pharmacol Exp Ther; 1994 Sep; 270(3):1239-45. PubMed ID: 7523656
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
[TBL] [Abstract][Full Text] [Related]
17. The role of nitric oxide in obstructive nephropathy.
Huang A; Palmer LS; Hom D; Valderrama E; Trachtman H
J Urol; 2000 Apr; 163(4):1276-81. PubMed ID: 10737528
[TBL] [Abstract][Full Text] [Related]
18. Novel potent and selective inhibitors of inducible nitric oxide synthase.
Nakane M; Klinghofer V; Kuk JE; Donnelly JL; Budzik GP; Pollock JS; Basha F; Carter GW
Mol Pharmacol; 1995 Apr; 47(4):831-4. PubMed ID: 7536889
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine.
Tozer GM; Prise VE; Chaplin DJ
Cancer Res; 1997 Mar; 57(5):948-55. PubMed ID: 9041200
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor.
Thomsen LL; Scott JM; Topley P; Knowles RG; Keerie AJ; Frend AJ
Cancer Res; 1997 Aug; 57(15):3300-4. PubMed ID: 9242464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
